GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Medite Cancer Diagnostics MDIT · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Medite Cancer Diagnostics — daily MDIT Delayed
Market value
$2,644
Last close × shares
Volume
88
Shares, 30 Oct 2026

About Medite Cancer Diagnostics

Its shares trade under the ticker MDIT. It has been listed since 27 October 1993. In the fiscal year to 31 December 2017, it reported revenue of $6.8m and a net loss of $6.8m. At that date it held total assets of $16.0m and shareholders' equity of $5.8m.

MEDITE Cancer Diagnostics, Inc. is a medical technology company which engages in cancer diagnostics instruments and consumables for histology and cytology laboratories. The company is headquartered in Chicago, Illinois. The firm develops, manufactures and sells a range of laboratory devices and consumable supplies for its target market in the histology and cytology cancer diagnostics segment. The firm offers a range of histology laboratory devices for processing tissue, from receiving the tissue in the laboratory to the final diagnosis. The firm offers USE33, an ultrasonic decalcification instrument that runs the process under controlled temperatures. The firm also offers TPC15 Duo or Trio, TES99, TES Valida, M530, A550, M380, TST44 and COT20 linear staining systems. In addition, the Company also offers RCM9000, ACS720 and TWISTER glass and robotic coverslippers.

Figures and description from our data supplier, not checked against the company's own report.

More about Medite Cancer Diagnostics →

Latest on Medite Cancer Diagnostics

Our reporting

We have not reported on Medite Cancer Diagnostics yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Medite Cancer Diagnostics's ticker?

Medite Cancer Diagnostics trades as MDIT on its US listing, under ISIN US58503D2009.

What was Medite Cancer Diagnostics's last closing price?

0.00 on 30 Oct 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.